ClinicalTrials.Veeva

Menu

Primary Tumor Burden Score:A Novel Staging Parameter for ESCC After nCRT

Fudan University logo

Fudan University

Status

Completed

Conditions

Neoplasm, Esophagus
Neoplasm, Squamous Cell

Treatments

Procedure: nCRT

Study type

Observational

Funder types

Other

Identifiers

NCT05839002
CMISG1708

Details and patient eligibility

About

In this case-only study, the investigators try to define a novel staging parameter, the Primary Tumor Burden Score (PTBS).

Full description

In this case-only study, the investigators try to define a novel staging parameter, the Primary Tumor Burden Score (PTBS), which will combine the proportion of residual primary tumor cells and pre-treatment pathological T stage (prepT stage). The investigators will also try to improve ypTNM stage by results of PTBS.

Enrollment

187 patients

Sex

All

Ages

40 to 79 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Neoadjuvant chemoradiotherapy and surgical resection of esophageal squamous cell carcinoma

Exclusion criteria

  • Patients receiving neoadjuvant chemoradiotherapy for esophageal squamous cell carcinoma without surgical resection

Trial design

187 participants in 2 patient groups

Training cohort
Description:
Training cohort will be used to find the best calculation and cut-off values for PTBS in ESCC after nCRT.
Treatment:
Procedure: nCRT
Validation cohort
Description:
The study's conclusion will be verified in Zhongshan Hospital Xiamen branch.
Treatment:
Procedure: nCRT

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems